Phillips Andrew's Insider Trades & SAST Disclosures
Phillips Andrew's most recent trade in Enliven Therapeutics Inc was a trade of 20,491 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Phillips Andrew.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enliven Therapeutics Inc | Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| OnKure Therapeutics Inc. -... | Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,300 | 15,300 | - | - | Stock Option (right to buy) | |
| MoonLake Immunotherapeutic... | Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,688 | 7,688 | - | - | Option to Buy | |
| Enliven Therapeutics Inc | Phillips Andrew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| MoonLake Immunotherapeutic... | Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 11,297 | 11,297 | - | - | Option to Buy | |
| Enliven Therapeutics Inc | Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) | |
| MoonLake Immunotherapeutic... | Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2022 | 45,000 | 45,000 | - | - | Option to Buy |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges